About: Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

AttributesValues
rdf:type
description
  • clinical trial (en)
  • клінічне випробування (uk)
  • կլինիկական փորձարկում (hy)
rdfs:label
  • Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects (en)
skos:prefLabel
  • Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects (en)
name
  • Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects (en)
title
title
  • A Phase 1, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of mRNA 1325 Zika Vaccine in Healthy Adults in a Non-endemic Zika Region (en)
end time
end time
instance of
instance of
start time
start time
medical condition treated
medical condition treated
research intervention
research intervention
sponsor
sponsor
number of participants
number of participants
study type
study type
ClinicalTrials.gov ID
ClinicalTrials.gov ID
  • NCT03014089
clinical trial phase
clinical trial phase
is about of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software